Regeneron Rallies After Seeking Emergency-Use Approval For Antibody Cocktail Taken By Trump
Tyler Durden
Thu, 10/08/2020 – 06:26
Shares of Regeneron are ripping higher Thursday in premarket trading, building on its gains from Wednesday evening, after the company submitted its COVID-19 antibody cocktail to the FDA for emergency-use approval.
The news follows President Trump’s full-throated endorsement of the therapy, which the president credited for his speedy recovery, calling the treatment a “cure” for COVID-19.
A MESSAGE FROM THE PRESIDENT! pic.twitter.com/uhLIcknAjT
— Donald J. Trump (@realDonaldTrump) October 7, 2020
Trump last night declared that he wants everyone who needs the treatment to get it, and added that the White House wants to “make it free for everyone.”
Of course, Regeneron isn’t the first drugmaker to file for an EUA from the FDA: Eli Lilly asked for approval for its antibody cocktail, which it said had been found to reduce viral load, symptoms and hospitalizations in patients.
via ZeroHedge News https://ift.tt/3dlmiI1 Tyler Durden